MOLLICA, VERONICA
MOLLICA, VERONICA
Dynamics of resistance to immunotherapy and TKI in patients with advanced renal cell carcinoma
2025 Santoni, Matteo; Mollica, Veronica; Rizzo, Alessandro; Massari, Francesco
State of the art of adjuvant immunotherapy in urothelial cancer: New developments and upcoming changes
2025 Tassinari, Elisa; Danielli, Linda; Marchetti, Andrea; Rosellini, Matteo; Ricci, Costantino; Piazza, Pietro; Mottaran, Angelo; Schiavina, Riccardo; Santoni, Matteo; Mollica, Veronica; Massari, Francesco
State of the art of adjuvant immunotherapy in urothelial cancer: New developments and upcoming changes
2025 Tassinari, Elisa; Danielli, Linda; Marchetti, Andrea; Rosellini, Matteo; Ricci, Costantino; Piazza, Pietro; Mottaran, Angelo; Schiavina, Riccardo; Santoni, Matteo; Mollica, Veronica; Massari, Francesco
A prospective study on the early evaluation of response to androgen receptor-targeted agents with 11C-Choline, 68Ga-PSMA, and 18F-FACBC PET in metastatic castration-resistant prostate cancer: a single-center experience
2024 Mollica, V.; Marchetti, A.; Fraccascia, N.; Nanni, C.; Tabacchi, E.; Malizia, C.; Argalia, G.; Rosellini, M.; Tassinari, E.; Paccapelo, A.; Fanti, S.; Massari, F.
Adjuvant treatment in renal cell carcinoma: a never-ending story?
2024 Mollica, Veronica; Massari, Francesco
Characterization of testicular embryonic-type neuroectodermal tumor and embryonic-type neuroectodermal tissue admixed with mature neuro-glial tissue using a broad immunohistochemical panel
2024 Di Sciascio, Luisa; Orsatti, Agnese; Ambrosi, Francesca; Franchini, Eugenia; Massari, Francesco; Mollica, Veronica; Bianchi, Federico Mineo; Colecchia, Maurizio; De Leo, Antonio; Acosta, Andres Martin; Lobo, João; Fiorentino, Michelangelo; Ricci, Costantino
Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis
2024 Rosellini, Matteo; Mollica, Veronica; Marchetti, Andrea; Coluccelli, Sara; Giunchi, Francesca; Tassinari, Elisa; Ricci, Costantino; Fiorentino, Michelangelo; Tallini, Giovanni; De Biase, Dario; Massari, Francesco
Clinical outcomes and prognostic factors in patients with penile carcinoma: a sub-analysis from Meet-URO 23 (I-RARE) registry study
2024 Mollica, Veronica; Massari, Francesco; Maruzzo, Marco; Bimbatti, Davide; Claps, Melanie; Maiorano, Brigida Anna; Vitale, Maria Giuseppa; Iacovelli, Roberto; Ermacora, Paola; Roviello, Giandomenico; Calabrò, Fabio; Caffo, Orazio; Vignani, Francesca; Grillone, Francesco; Pierantoni, Francesco; Napoli, Marilena Di; Mennitto, Alessia; Marchetti, Andrea; Mattana, Alvise; Cavo, Alessia; Bassanelli, Maria; Formisano, Luigi; Prati, Veronica; Giudice, Giulia Claire; Buti, Sebastiano
Efficacy of Immune Checkpoint Inhibitors Combinations as First-Line Systemic Treatment in Patients with Advanced Urothelial Carcinoma: A Systematic Review and Network Meta-Analysis
2024 Monteiro, Fernando Sabino Marques; Soares, Andrey; Mollica, Veronica; Leite, Caio Abner; Dias Carneiro, Andre Paterno Castello; Rizzo, Alessandro; Bourlon, Maria T; Sasse, Andre Deeke; Santoni, Matteo; Gupta, Shilpa; Massari, Francesco
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations
2024 Maffezzoli, Michele; Santoni, Matteo; Mazzaschi, Giulia; Rodella, Sara; Lai, Eleonora; Maruzzo, Marco; Basso, Umberto; Bimbatti, Davide; Iacovelli, Roberto; Anghelone, Annunziato; Fiala, Ondřej; Rebuzzi, Sara Elena; Fornarini, Giuseppe; Lolli, Cristian; Massari, Francesco; Rosellini, Matteo; Mollica, Veronica; Nasso, Cecilia; Acunzo, Alessandro; Silini, Enrico Maria; Quaini, Federico; De Filippo, Massimo; Brunelli, Matteo; Banna, Giuseppe L; Rescigno, Pasquale; Signori, Alessio; Buti, Sebastiano
Immunophenotypical assessment supports that post-chemotherapy glandular tumours of germ cell origin straddle between glandular yolk sac tumour and ‘somatic-type’ adenocarcinoma
2024 Ricci C.; Ambrosi F.; Grillini A.; Grillini M.; Mollica V.; Fiorentino M.; Sangoi A.R.; De Leo A.; Idrees M.T.; Ulbright T.M.; Acosta A.M.
Novel Immune Checkpoint Inhibitor Targets in Advanced or Metastatic Renal Cell Carcinoma: State of the Art and Future Perspectives
2024 Compagno, Samuele; Casadio, Chiara; Galvani, Linda; Rosellini, Matteo; Marchetti, Andrea; Tassinari, Elisa; Piazza, Pietro; Mottaran, Angelo; Santoni, Matteo; Schiavina, Riccardo; Massari, Francesco; Mollica, Veronica
Pembrolizumab plus enfortumab vedotin in urothelial cancer
2024 Santoni, Matteo; Takeshita, Hideki; Massari, Francesco; Bamias, Aristotelis; Cerbone, Linda; Fiala, Ondrej; Mollica, Veronica; Buti, Sebastiano; Santoni, Angela; Bellmunt, Joaquim
Tumor growth rate to assess therapy response to immune-based combinations for metastatic renal cell carcinoma
2024 Mollica, Veronica; Rosellini, Matteo; Brocchi, Stefano; Galuppi, Francesco; Paccapelo, Alexandro; Tateo, Valentina; Marchetti, Andrea; Tassinari, Elisa; Mantuano, Francesco; Santoni, Matteo; Massari, Francesco
What is the risk of hepatotoxicity induced by immune-checkpoint inhibitors and how can we avoid it?
2024 Tassinari, Elisa; Rosellini, Matteo; Marchetti, Andrea; Mollica, Veronica; Massari, Francesco
Adapting to hormone-therapy resistance for adopting the right therapeutic strategy in advanced prostate cancer
2023 Nuvola, Giacomo; Santoni, Matteo; Rizzo, Mimma; Rosellini, Matteo; Mollica, Veronica; Rizzo, Alessandro; Marchetti, Andrea; Battelli, Nicola; Massari, Francesco
Agnostic Approvals in Oncology: Getting the Right Drug to the Right Patient with the Right Genomics
2023 Valentina Tateo; Paola Valeria Marchese; Veronica Mollica; Francesco Massari; Razelle Kurzrock; Jacob J. Adashek
An update on safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma
2023 Rosellini, Matteo; Tassinari, Elisa; Marchetti, Andrea; Tateo, Valentina; Nuvola, Giacomo; Rizzo, Alessandro; Massari, Francesco; Mollica, Veronica
Belzutifan: enhancing the blockade of angiogenesis in renal cell carcinoma
2023 Mollica, Veronica; Massari, Francesco
Bone targeting agents, but not radiation therapy, improves survival in patients with bone metastases from advanced urothelial carcinoma receiving pembrolizumab: results from the ARON-2 study
2023 Santoni, Matteo; Massari, Francesco; Takeshita, Hideki; Tapia, Jose Carlos; Dionese, Michele; Pichler, Renate; Rizzo, Mimma; Lam, Elaine T; Grande, Enrique; Kemp, Robert; Molina-Cerrillo, Javier; Calabrò, Fabio; Tural, Deniz; Küronya, Zsófia; Kucharz, Jakub; Fiala, Ondrej; Seront, Emmanuel; Kopp, Ray Manneh; Abahssain, Halima; Kopecky, Jindrich; Martignetti, Angelo; Kanesvaran, Ravindran; Zakopoulou, Roubini; Ansari, Jawaher; Landmesser, Johannes; Mollica, Veronica; Porta, Camillo; Bellmunt, Joaquim; Salah, Samer; Santini, Daniele
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Dynamics of resistance to immunotherapy and TKI in patients with advanced renal cell carcinoma | Santoni, Matteo; Mollica, Veronica; Rizzo, Alessandro; Massari, Francesco | 2025-01-01 | CANCER TREATMENT REVIEWS | - | 1.01 Articolo in rivista | 1001306.pdf |
| State of the art of adjuvant immunotherapy in urothelial cancer: New developments and upcoming changes | Tassinari, Elisa; Danielli, Linda; Marchetti, Andrea; Rosellini, Matteo; Ricci, Costantino; Piazz...a, Pietro; Mottaran, Angelo; Schiavina, Riccardo; Santoni, Matteo; Mollica, Veronica; Massari, Francesco | 2025-01-01 | HUMAN VACCINES & IMMUNOTHERAPEUTICS | - | 1.01 Articolo in rivista | - |
| State of the art of adjuvant immunotherapy in urothelial cancer: New developments and upcoming changes | Tassinari, Elisa; Danielli, Linda; Marchetti, Andrea; Rosellini, Matteo; Ricci, Costantino; Piazz...a, Pietro; Mottaran, Angelo; Schiavina, Riccardo; Santoni, Matteo; Mollica, Veronica; Massari, Francesco | 2025-01-01 | HUMAN VACCINES & IMMUNOTHERAPEUTICS | - | 1.01 Articolo in rivista | State of the art of adjuvant immunotherapy in urothelial cancer New developments and upcoming changes.pdf |
| A prospective study on the early evaluation of response to androgen receptor-targeted agents with 11C-Choline, 68Ga-PSMA, and 18F-FACBC PET in metastatic castration-resistant prostate cancer: a single-center experience | Mollica, V.; Marchetti, A.; Fraccascia, N.; Nanni, C.; Tabacchi, E.; Malizia, C.; Argalia, G.; Ro...sellini, M.; Tassinari, E.; Paccapelo, A.; Fanti, S.; Massari, F. | 2024-01-01 | ESMO OPEN | - | 1.01 Articolo in rivista | ESMO Open 2024.pdf; appendix.docx |
| Adjuvant treatment in renal cell carcinoma: a never-ending story? | Mollica, Veronica; Massari, Francesco | 2024-01-01 | THE LANCET | - | 1.01 Articolo in rivista | - |
| Characterization of testicular embryonic-type neuroectodermal tumor and embryonic-type neuroectodermal tissue admixed with mature neuro-glial tissue using a broad immunohistochemical panel | Di Sciascio, Luisa; Orsatti, Agnese; Ambrosi, Francesca; Franchini, Eugenia; Massari, Francesco; ...Mollica, Veronica; Bianchi, Federico Mineo; Colecchia, Maurizio; De Leo, Antonio; Acosta, Andres Martin; Lobo, João; Fiorentino, Michelangelo; Ricci, Costantino | 2024-01-01 | VIRCHOWS ARCHIV | - | 1.01 Articolo in rivista | - |
| Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis | Rosellini, Matteo; Mollica, Veronica; Marchetti, Andrea; Coluccelli, Sara; Giunchi, Francesca; Ta...ssinari, Elisa; Ricci, Costantino; Fiorentino, Michelangelo; Tallini, Giovanni; De Biase, Dario; Massari, Francesco | 2024-01-01 | PATHOLOGY, RESEARCH AND PRACTICE | - | 1.01 Articolo in rivista | - |
| Clinical outcomes and prognostic factors in patients with penile carcinoma: a sub-analysis from Meet-URO 23 (I-RARE) registry study | Mollica, Veronica; Massari, Francesco; Maruzzo, Marco; Bimbatti, Davide; Claps, Melanie; Maiorano..., Brigida Anna; Vitale, Maria Giuseppa; Iacovelli, Roberto; Ermacora, Paola; Roviello, Giandomenico; Calabrò, Fabio; Caffo, Orazio; Vignani, Francesca; Grillone, Francesco; Pierantoni, Francesco; Napoli, Marilena Di; Mennitto, Alessia; Marchetti, Andrea; Mattana, Alvise; Cavo, Alessia; Bassanelli, Maria; Formisano, Luigi; Prati, Veronica; Giudice, Giulia Claire; Buti, Sebastiano | 2024-01-01 | CLINICAL GENITOURINARY CANCER | - | 1.01 Articolo in rivista | - |
| Efficacy of Immune Checkpoint Inhibitors Combinations as First-Line Systemic Treatment in Patients with Advanced Urothelial Carcinoma: A Systematic Review and Network Meta-Analysis | Monteiro, Fernando Sabino Marques; Soares, Andrey; Mollica, Veronica; Leite, Caio Abner; Dias Car...neiro, Andre Paterno Castello; Rizzo, Alessandro; Bourlon, Maria T; Sasse, Andre Deeke; Santoni, Matteo; Gupta, Shilpa; Massari, Francesco | 2024-01-01 | CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations | Maffezzoli, Michele; Santoni, Matteo; Mazzaschi, Giulia; Rodella, Sara; Lai, Eleonora; Maruzzo, M...arco; Basso, Umberto; Bimbatti, Davide; Iacovelli, Roberto; Anghelone, Annunziato; Fiala, Ondřej; Rebuzzi, Sara Elena; Fornarini, Giuseppe; Lolli, Cristian; Massari, Francesco; Rosellini, Matteo; Mollica, Veronica; Nasso, Cecilia; Acunzo, Alessandro; Silini, Enrico Maria; Quaini, Federico; De Filippo, Massimo; Brunelli, Matteo; Banna, Giuseppe L; Rescigno, Pasquale; Signori, Alessio; Buti, Sebastiano | 2024-01-01 | CLINICAL & EXPERIMENTAL METASTASIS | - | 1.01 Articolo in rivista | Clin Exp Metastasis 2024 [Red cell Buti].pdf; 10585_2024_10266_MOESM1_ESM.docx |
| Immunophenotypical assessment supports that post-chemotherapy glandular tumours of germ cell origin straddle between glandular yolk sac tumour and ‘somatic-type’ adenocarcinoma | Ricci C.; Ambrosi F.; Grillini A.; Grillini M.; Mollica V.; Fiorentino M.; Sangoi A.R.; De Leo A....; Idrees M.T.; Ulbright T.M.; Acosta A.M. | 2024-01-01 | HISTOPATHOLOGY | - | 1.01 Articolo in rivista | - |
| Novel Immune Checkpoint Inhibitor Targets in Advanced or Metastatic Renal Cell Carcinoma: State of the Art and Future Perspectives | Compagno, Samuele; Casadio, Chiara; Galvani, Linda; Rosellini, Matteo; Marchetti, Andrea; Tassina...ri, Elisa; Piazza, Pietro; Mottaran, Angelo; Santoni, Matteo; Schiavina, Riccardo; Massari, Francesco; Mollica, Veronica | 2024-01-01 | JOURNAL OF CLINICAL MEDICINE | - | 1.01 Articolo in rivista | Novel Immune Checkpoint Inhibitor Targets in Advanced.pdf |
| Pembrolizumab plus enfortumab vedotin in urothelial cancer | Santoni, Matteo; Takeshita, Hideki; Massari, Francesco; Bamias, Aristotelis; Cerbone, Linda; Fial...a, Ondrej; Mollica, Veronica; Buti, Sebastiano; Santoni, Angela; Bellmunt, Joaquim | 2024-01-01 | NATURE REVIEWS. UROLOGY | - | 1.01 Articolo in rivista | - |
| Tumor growth rate to assess therapy response to immune-based combinations for metastatic renal cell carcinoma | Mollica, Veronica; Rosellini, Matteo; Brocchi, Stefano; Galuppi, Francesco; Paccapelo, Alexandro;... Tateo, Valentina; Marchetti, Andrea; Tassinari, Elisa; Mantuano, Francesco; Santoni, Matteo; Massari, Francesco | 2024-01-01 | EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT | - | 1.01 Articolo in rivista | ERPMDD 2024 [TGR].pdf |
| What is the risk of hepatotoxicity induced by immune-checkpoint inhibitors and how can we avoid it? | Tassinari, Elisa; Rosellini, Matteo; Marchetti, Andrea; Mollica, Veronica; Massari, Francesco | 2024-01-01 | EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | - | 1.01 Articolo in rivista | - |
| Adapting to hormone-therapy resistance for adopting the right therapeutic strategy in advanced prostate cancer | Nuvola, Giacomo; Santoni, Matteo; Rizzo, Mimma; Rosellini, Matteo; Mollica, Veronica; Rizzo, Ales...sandro; Marchetti, Andrea; Battelli, Nicola; Massari, Francesco | 2023-01-01 | EXPERT REVIEW OF ANTICANCER THERAPY | - | 1.01 Articolo in rivista | - |
| Agnostic Approvals in Oncology: Getting the Right Drug to the Right Patient with the Right Genomics | Valentina Tateo; Paola Valeria Marchese; Veronica Mollica; Francesco Massari; Razelle Kurzrock; J...acob J. Adashek | 2023-01-01 | PHARMACEUTICALS | - | 1.01 Articolo in rivista | Pharmaceuticals 2023 [Agnostic].pdf |
| An update on safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma | Rosellini, Matteo; Tassinari, Elisa; Marchetti, Andrea; Tateo, Valentina; Nuvola, Giacomo; Rizzo,... Alessandro; Massari, Francesco; Mollica, Veronica | 2023-01-01 | EXPERT OPINION ON DRUG SAFETY | - | 1.01 Articolo in rivista | - |
| Belzutifan: enhancing the blockade of angiogenesis in renal cell carcinoma | Mollica, Veronica; Massari, Francesco | 2023-01-01 | THE LANCET ONCOLOGY | - | 1.01 Articolo in rivista | Lancet_Oncol_AM.pdf |
| Bone targeting agents, but not radiation therapy, improves survival in patients with bone metastases from advanced urothelial carcinoma receiving pembrolizumab: results from the ARON-2 study | Santoni, Matteo; Massari, Francesco; Takeshita, Hideki; Tapia, Jose Carlos; Dionese, Michele; Pic...hler, Renate; Rizzo, Mimma; Lam, Elaine T; Grande, Enrique; Kemp, Robert; Molina-Cerrillo, Javier; Calabrò, Fabio; Tural, Deniz; Küronya, Zsófia; Kucharz, Jakub; Fiala, Ondrej; Seront, Emmanuel; Kopp, Ray Manneh; Abahssain, Halima; Kopecky, Jindrich; Martignetti, Angelo; Kanesvaran, Ravindran; Zakopoulou, Roubini; Ansari, Jawaher; Landmesser, Johannes; Mollica, Veronica; Porta, Camillo; Bellmunt, Joaquim; Salah, Samer; Santini, Daniele | 2023-01-01 | CLINICAL AND EXPERIMENTAL MEDICINE | - | 1.01 Articolo in rivista | 947373_merged.pdf |